New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Biking, Prostate Cancer Risk Investigated

Cyclists who bike more may face a higher risk of prostate cancer, but not a greater chance of infertility or erectile dysfunction.

Could Statins Cut Breast Cancer Risk?

Women with hyperlipidemia have an increased risk of developing breast cancer, according to a new study.

Vaccine-Chemo for Pancreatic Cancer

The results of a new trial are extremely promising for the efficacy of a vaccine-chemotherapy combination for pancreatic cancer.

Novel Gene Mutations and Lung Cancer

Researchers have identified genetic mutations in the cell signaling pathway RTK/RAS/RAF that can lead to lung adenocarcinoma.

Corticosteroids for Cancer Pain?

Even with limited evidence as to their efficacy, corticosteroids are often included in cancer pain management therapy.

No Fertility Drug-Cancer Link

Use of fertility drugs doesn't appear to increase a woman's long-term risk of breast, ovarian, and uterine cancers, new research indicates.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.


Contralateral Prophylactic Mastectomy Benefit Questioned

Contralateral Prophylactic Mastectomy Benefit Questioned

For women with stage I or II breast cancer without a BRCA mutation, contralateral prophylactic mastectomy (CPM) is associated with an absolute 20-year survival benefit of <1%.

Uterine Cancer in Morcellation Increases with Age

Uterine Cancer in Morcellation Increases with Age

For women undergoing hysterectomy by morcellation, the prevalence of uterine cancers is 27 per 10,000, with increased prevalence with advanced age.

Zydelig Approved for Three B-Cell Blood Cancers

The FDA has approved Zydelig (idelalisib; Gilead Sciences) for relapsed chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL), and small lymphocytic lymphoma (SLL).

Neratinib Demonstrates Potential in Breast Cancer Trial

Puma Biotechnology announced results from its Phase 3 ExteNET trial of neratinib (PB272) for the extended adjuvant treatment of breast cancer.


Make prescribing decisions with our comparative charts and treatment algorithms.


Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Understanding Current and Emerging Therapies for Head and Neck CancersExternal web site

This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...

CE 0.50 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Sign Up for Free e-newsletters